Login / Signup

(E1)levating COVID-19 vaccine efficiency with adenoviral E1 proteins.

Douglas R GreenPaul Glyndwr Thomas
Published in: Science advances (2022)
Improved adenovirus-based COVID-19 vaccines provide an important tool to combat the ever-evolving virus.
Keyphrases
  • coronavirus disease
  • sars cov
  • gene therapy